AXSOME THERAPEUTICS, INC. Number of Reporting Units
AXSOME THERAPEUTICS, INC. (AXSM) reported Number of Reporting Units of 1 ReportingUnits for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. number of reporting units for the quarter ending 2026-03-31 was 1.00 ReportingUnits, a 0.00% change year-over-year.
- AXSOME THERAPEUTICS, INC. number of reporting units for the quarter ending 2025-03-31 was 1.00 ReportingUnits, a 0.00% change year-over-year.
- AXSOME THERAPEUTICS, INC. number of reporting units for the quarter ending 2024-03-31 was 1.00 ReportingUnits, a 0.00% change year-over-year.
- AXSOME THERAPEUTICS, INC. number of reporting units for the quarter ending 2023-03-31 was 1.00 ReportingUnits.
- AXSOME THERAPEUTICS, INC. number of reporting units for fiscal 2025 was 1.00 ReportingUnits, a 0.00% change from fiscal 2024.
- AXSOME THERAPEUTICS, INC. number of reporting units for fiscal 2024 was 1.00 ReportingUnits, a 0.00% change from fiscal 2023.
- AXSOME THERAPEUTICS, INC. number of reporting units for fiscal 2023 was 1.00 ReportingUnits, a 0.00% change from fiscal 2022.
- AXSOME THERAPEUTICS, INC. number of reporting units for fiscal 2022 was 1.00 ReportingUnits.
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 6 month | Number of Reporting Units 9 month | Number of Reporting Units 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 ReportingUnits 10-Q · filed 2026-08-10 | |||
| 2026-03-31 | 1.00 ReportingUnits 10-Q · filed 2026-05-04 | |||
| 2025-12-31 | 1.00 ReportingUnits 10-K · filed 2026-02-23 | |||
| 2025-09-30 | 1.00 ReportingUnits 10-Q · filed 2025-11-03 | |||
| 2025-06-30 | 1.00 ReportingUnits 10-Q · filed 2025-08-04 | |||
| 2025-03-31 | 1.00 ReportingUnits 10-Q · filed 2025-05-05 | |||
| 2024-12-31 | 1.00 ReportingUnits 10-K · filed 2025-02-18 | |||
| 2024-09-30 | 1.00 ReportingUnits 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | 1.00 ReportingUnits 10-Q · filed 2024-08-05 | |||
| 2024-03-31 | 1.00 ReportingUnits 10-Q · filed 2024-05-06 | |||
| 2023-12-31 | 1.00 ReportingUnits 10-K · filed 2024-02-23 | |||
| 2023-09-30 | 1.00 ReportingUnits 10-Q · filed 2023-11-06 | |||
| 2023-06-30 | 1.00 ReportingUnits 10-Q · filed 2023-08-07 | |||
| 2023-03-31 | 1.00 ReportingUnits 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | 1.00 ReportingUnits 10-K · filed 2023-02-28 | |||
| 2022-09-30 | 1.00 ReportingUnits 10-Q · filed 2022-11-07 | |||
| 2022-06-30 | 1.00 ReportingUnits 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |